123 related articles for article (PubMed ID: 37080857)
81. Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients.
Caramanna I; Klein M; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Reijneveld JC;
Qual Life Res; 2022 Nov; 31(11):3253-3266. PubMed ID: 35982202
[TBL] [Abstract][Full Text] [Related]
82. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
Gough N; Koffman J; Ross JR; Riley J; Judson I
PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
[TBL] [Abstract][Full Text] [Related]
83. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
[TBL] [Abstract][Full Text] [Related]
84. Patient-reported cognitive function before and after glioma surgery.
Schei S; Solheim O; Salvesen Ø; Hansen TI; Sagberg LM
Acta Neurochir (Wien); 2022 Aug; 164(8):2009-2019. PubMed ID: 35668303
[TBL] [Abstract][Full Text] [Related]
85. Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades.
Boele FW; den Otter PWM; Reijneveld JC; de Witt Hamer PC; van Thuijl HF; Lorenz LMC; Wesseling P; Lagerwaard FJ; Taphoorn MJB; Kouwenhoven MCM; Snijders TJ; Douw L; Klein M
Neuro Oncol; 2023 Feb; 25(2):351-364. PubMed ID: 35908832
[TBL] [Abstract][Full Text] [Related]
86. Health-related Quality of Life Assessment in Patients with Malignant Gliomas.
Taskiran E; Kemerdere R; Akgun MY; Cetintas SC; Alizada O; Kacira T; Tanriverdi T
Neurol India; 2021; 69(6):1613-1618. PubMed ID: 34979651
[TBL] [Abstract][Full Text] [Related]
87. Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK + non-small cell lung cancer (ALTA-1L).
Garcia Campelo MR; Lin HM; Zhu Y; Pérol M; Jahanzeb M; Popat S; Zhang P; Camidge DR
Lung Cancer; 2021 May; 155():68-77. PubMed ID: 33744781
[TBL] [Abstract][Full Text] [Related]
88. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
89. Cognitive functions in low-grade gliomas: disease and treatment effects.
Correa DD; DeAngelis LM; Shi W; Thaler HT; Lin M; Abrey LE
J Neurooncol; 2007 Jan; 81(2):175-84. PubMed ID: 16850104
[TBL] [Abstract][Full Text] [Related]
90. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
Douw L; Klein M; Fagel SS; van den Heuvel J; Taphoorn MJ; Aaronson NK; Postma TJ; Vandertop WP; Mooij JJ; Boerman RH; Beute GN; Sluimer JD; Slotman BJ; Reijneveld JC; Heimans JJ
Lancet Neurol; 2009 Sep; 8(9):810-8. PubMed ID: 19665931
[TBL] [Abstract][Full Text] [Related]
91. Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
Coomans MB; Dirven L; Aaronson NK; Baumert BG; Van Den Bent M; Bottomley A; Brandes AA; Chinot O; Coens C; Gorlia T; Herrlinger U; Keime-Guibert F; Malmström A; Martinelli F; Stupp R; Talacchi A; Weller M; Wick W; Reijneveld JC; Taphoorn MJB
Neuro Oncol; 2019 Nov; 21(11):1447-1457. PubMed ID: 31682733
[TBL] [Abstract][Full Text] [Related]
92. Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.
Laquente B; Macarulla T; Bugés C; Martín M; García C; Pericay C; Merino S; Visa L; Martín T; Pedraza M; Carnero B; Guardeño R; Verdaguer H; Mut A; Vilanova D; García A
BMC Palliat Care; 2020 Jul; 19(1):103. PubMed ID: 32650765
[TBL] [Abstract][Full Text] [Related]
93. Factors associated with health-related quality of life in patients with glioma: impact of symptoms and implications for rehabilitation.
Umezaki S; Shinoda Y; Mukasa A; Tanaka S; Takayanagi S; Oka H; Tagawa H; Haga N; Yoshino M
Jpn J Clin Oncol; 2020 Sep; 50(9):990-998. PubMed ID: 32484212
[TBL] [Abstract][Full Text] [Related]
94. Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life.
Stöckelmaier L; Renovanz M; König J; Nickel K; Hickmann AK; Mayer-Steinacker R; Nadji-Ohl M; Ganslandt O; Bullinger L; Wirtz CR; Coburger J
World Neurosurg; 2017 Jun; 102():383-399. PubMed ID: 28288921
[TBL] [Abstract][Full Text] [Related]
95. Severity of Financial Toxicity for Patients Receiving Palliative Radiation Therapy.
Harris JP; Ku E; Harada G; Hsu S; Chiao E; Rao P; Healy E; Nagasaka M; Humphreys J; Hoyt MA
Am J Hosp Palliat Care; 2024 Jun; 41(6):592-600. PubMed ID: 37406195
[No Abstract] [Full Text] [Related]
96. Long Term Outcome and Quality of Life of Intracranial Meningioma Patients Treated with Pencil Beam Scanning Proton Therapy.
Krcek R; Leiser D; García-Marqueta M; Bolsi A; Weber DC
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370709
[TBL] [Abstract][Full Text] [Related]
97. Investigation of high-dose radiotherapy's effect on brain structure aggravated cognitive impairment and deteriorated patient psychological status in brain tumor treatment.
Ma J; Cao H; Hou D; Wang W; Liu T
Sci Rep; 2024 May; 14(1):10149. PubMed ID: 38698048
[TBL] [Abstract][Full Text] [Related]
98. High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.
Pöhlmann J; Weller M; Marcellusi A; Grabe-Heyne K; Krott-Coi L; Rabar S; Pollock RF
Front Oncol; 2024; 14():1368606. PubMed ID: 38571509
[TBL] [Abstract][Full Text] [Related]
99. Neural and Onconeural Autoantibodies and Blood-Brain Barrier Disruption Markers in Patients Undergoing Radiotherapy for High-Grade Primary Brain Tumour.
Hojan K; Adamska K; Lewandowska A; Procyk D; Leporowska E; Osztynowicz K; Michalak S
Diagnostics (Basel); 2024 Jan; 14(3):. PubMed ID: 38337823
[TBL] [Abstract][Full Text] [Related]
100. Brain Plasticity Profiling as a Key Support to Therapeutic Decision-Making in Low-Grade Glioma Oncological Strategies.
Ng S; Duffau H
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
